Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Overview
  • Distribution
  • Guaranteed Paid Placement
  • SocialBoost
  • Multichannel Amplification
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Overview
  • Distribution by PR Newswire
  • Guaranteed Paid Placement
  • SocialBoost
  • Multichannel Amplification
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Thailand Emerges as Southeast Asia's Prime Destination for Biotechnology Development
  • USA - English


News provided by

Thailand Board of Investment (BOI)

14 Nov, 2017, 19:39 IST

Share this article

Share toX

Share this article

Share toX

BANGKOK, Nov. 14, 2017 /PRNewswire/ -- Biotechnology in Thailand has been through over three decades of development. Today, with its superb infrastructure, substantial scientific capability and strategic location in the center of the Southeast Asia region, Thailand is home to many well-established world tech labs and pharma companies, and is ready to embrace new wave of advanced biotech development. Bio economy is also a new ambition of the Thai government, one of the ten targeted growth-engine industries under the new "Thailand 4.0" growth model, which focuses on the concept of inclusive, productive and green growth to enhance the country's competitiveness and economic development.

Photo - https://mma.prnewswire.com/media/603668/BOI_Logo.jpg

Biotech companies in Thailand enjoy a variety of competitive advantages from supporting ecosystems including intellectual property protections and technically-equipped workforce as well as an abundance of natural resources and rich biological diversity.

The Board of Investment (BOI) recognizes the importance and value of the bio economy industry, and offers a wide range of tax and non-tax incentives for projects that meet national development objectives. Tax incentives for biotechnology companies investing in Thailand include an 8-year corporate income tax holiday and exemption of import duties on machinery and raw materials used for manufacturing of export products. Non-tax incentives are visa and work permit for foreign experts, permit to own land and permit to take or remit foreign currency abroad. In addition, products or raw materials brought in for research and development also receive import duty exemption.

Moreover, the National Science and Technology Development Agency (NSTDA) provides government and organizational support. Through the operation of four national research centers, including BIOTEC, MTEC, NANOTEC, and NECTEC, and a technology management center (TMC), NSTDA acts as a bridge between the requirements for academic research and innovation in the industry.

Thailand has developed network of organizations that support research and development in biotech. Currently, 24 universities across the country have the combined capacity to supply approximately 7,000 students with a biotechnology background each year. In addition, well-established research infrastructure, including various pilot plants located in several leading universities across the country, allows biotech companies to scale up their research before commercializing their innovations. Many of these pilot plants operate as private and public sector partnership, such as the Agricultural Research Development Agency (ARDA) under the Ministry of Agriculture. 

Diverse natural resources, biology and thriving agricultural sector assist Thailand to be a research hub for biotechnology. Its hot and humid climate supports tropical ecosystems that a large variety of plant, animal and microbe species survive. Thailand has approximately 15,000 species of plants which account for approximately 10% of the estimated total number of plant species found globally. Moreover, abundant farmland across the country and a year-round growing season allow agricultural raw materials to be sourced from locally at low prices. Meanwhile, Thai agricultural sector, the mainstay of the country's socioeconomic foundation, is currently transitioning to 'Smart Farming', a key reforming process endorsed by the government to increase the efficiency of agricultural production and enhance cooperation between farmers and the public and private sectors.

Thailand Science Park (TSP), the first technology and innovation hub of Thailand, serves as a one-stop service center to assist both foreign and local companies engaged in scientific and technological research. TSP is a key hub for research and development where specialists and researchers from the industry, the academia and NSTDA collaborate to further inspire and stimulate the formation and growth of the knowledge-based businesses. A network of 1,600 full-time researchers and technicians, of which around 400 hold doctorate degrees, can be found at TSP. TMC also provides important support to biotechnology through its Technology Licensing Office (TLO), which is responsible for the licensing of intellectual property.

The recent setting up of the Strategic Talent Center (STC) helps enhance the country's ecosystem for stronger research and development capability. The center serves as a platform interacting with the private sector in identifying available specialists or researchers in science and technology to support the private sector in conducting R&D and innovation activities. The STC will be actively involved by matching their skills and expertise with real demands from the requesting companies.

For more information, please contact [email protected] or visit www.boi.go.th.

The Board of Investment of Thailand (BOI)
Raweechay Atthakhosolsuradi
Tel. +66 (0) 2553 8111 Ext. 6932

Modal title

Also from this source

Thailand's Government Reaffirms Commitment to Strengthen Competitiveness in Dialogue With 30 Global Investors

Thailand's Government Reaffirms Commitment to Strengthen Competitiveness in Dialogue With 30 Global Investors

Thailand's Acting Prime Minister Mr. Phumtham Wechayachai today welcomed senior executives from 30 global companies from diverse sectors, which have...

BOI Highlights Thailand's Competitive Edge as U.S.-Thailand Trade Deal Takes Effect

BOI Highlights Thailand's Competitive Edge as U.S.-Thailand Trade Deal Takes Effect

Following the issuance by U.S. President Donald Trump of an executive order that adjusted tariffs on Thailand and other countries, Mr. Narit...

More Releases From This Source

Explore

Biotechnology

Biotechnology

Pharmaceuticals

Pharmaceuticals

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.